<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Haemodialysis patients show sympathetic <z:hpo ids='HP_0000752'>hyperactivity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Hyperactivation of the sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system aggravates <z:hpo ids='HP_0000822'>hypertension</z:hpo> and it is related to <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo>, <z:hpo ids='HP_0001635'>heart failure</z:hpo>, <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and atherogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>We report the first use of renal sympathetic nerve ablation for correction of uncontrolled <z:hpo ids='HP_0000822'>hypertension</z:hpo> in an <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> patient on maintenance dialysis </plain></SENT>
<SENT sid="3" pm="."><plain>We observed a progressive and sustained reduction of systemic blood pressure </plain></SENT>
<SENT sid="4" pm="."><plain>Our case demonstrates the safety, the feasibility and the efficacy of this procedure </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggest, however, that further clinical trials are needed into renal nerve radiofrequency ablation therapy for the treatment of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and for the improvement of cardiovascular prognosis in this high-risk patient group </plain></SENT>
</text></document>